NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Receives New Coverage from Analysts at StockNews.com

StockNews.com started coverage on shares of NovaBay Pharmaceuticals (NYSEAMERICAN:NBY – Get Rating) in a research note issued to investors on Friday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. NovaBay Pharmaceuticals Trading Up 1.6 % NovaBay Pharmaceuticals stock opened at $0.61 on Friday. The company has a market cap of $1.14 million, […]

Related Keywords

,Virtu Financial ,Novabay Pharmaceuticals Inc ,News Ratings For Novabay Pharmaceuticals Daily ,Renaissance Technologies ,Novabay Pharmaceuticals Trading ,Armistice Capital ,Hedge Funds Weigh In On Novabay Pharmaceuticals ,Novabay Pharmaceuticals ,Get Rating ,Bay Pharmaceuticals ,Capital Management ,Novabay Pharmaceuticals Daily ,Nyseamerican Nby ,Anby ,Medical ,Initiated Coverage ,Stocknews Com ,